6558 — SYNergy ScienTech Income Statement
0.000.00%
- TWD2.71bn
- TWD2.31bn
- TWD1.07bn
Annual income statement for SYNergy ScienTech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,691 | 1,148 | 1,197 | 1,159 | 1,073 |
| Cost of Revenue | |||||
| Gross Profit | 277 | 109 | 167 | 218 | 201 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,662 | 1,271 | 1,260 | 1,195 | 1,162 |
| Operating Profit | 29.1 | -122 | -63.6 | -35.3 | -89.4 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 5.75 | -86.2 | -45.5 | 15.7 | -97.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.28 | -61 | -44.7 | 9.57 | -95.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.28 | -61 | -44.7 | 9.57 | -95.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 3.28 | -61 | -44.7 | 9.57 | -95.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.043 | -0.612 | -0.44 | 0.102 | -0.779 |
| Dividends per Share |